https://orcid.org/0000-0002-9721-0308
References
- Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med. 2016;140(7):698–713.
- Redline RW, Ravishankar S. Fetal vascular malperfusion, an update. APMIS. 2018;126(7):561–569.
- Lepais L, Gaillot-Durand L, Boutitie F, et al. Fetal thrombotic vasculopathy is associated with thromboembolic events and adverse perinatal outcome but not with neurologic complications: a retrospective cohort study of 54 cases with a 3-year follow-up of children. Placenta. 2014;35(8):611–617.
- Raymond RW. Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. Hum Pathol. 2004;35:1494–1498.
- Wintermark P, Boyd T, Parast MM, et al. Fetal placental thrombosis and neonatal implications. Am J Perinatol. 2010;27(3):251–256.
- Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192(2):452–457.
- Kraus FT, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol. 1999;30(7):759–769.
- McDonald DG, Kelehan P, McMenamin JB, et al. Placental fetal thrombotic vasculopathy is associated with neonatal encephalopathy. Hum Pathol. 2004;35(7):875–880.
- Tamblyn JA, Lissauer DM, Powell R, et al. The immunological basis of villitis of unknown etiology – review. Placenta. 2013;34(10):846–855.
- Jessop F, Sebire NJ. Histological chorioamnionitis: current concepts of diagnosis, classification and clinical significance. Fetal Matern Med Rev. 2011;22(1):25–44.
- Salafia CM, Pezzullo JC, Minior VK, et al. Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol. 1997;90(5):830–836.
- Baergen RN. Macroscopic evaluation of the second and third-trimester placenta. In: Baergen RN, editor. Manual of pathology of the human placenta. New York: Springer Science & Business Media LLC; 2011. p. 32–33.
- Ravikumar G, Crasta J, Prabhu JS, et al. Eccentric placentae have reduced surface area and are associated with lower birth weight in babies small for gestational age. J Dev Orig Health Dis. 2018;9(3):281–286.
- Cooley SM, Reidy FR, Mooney EE, et al. Antenatal suspicion of ischemic placental disease and coexistence of maternal and fetal placental disease: analysis of over 500 cases. Am J Obstet Gynecol. 2011;205(6):576.e1–576.e6.
- Pathak S, Lees CC, Hackett G, et al. Frequency and clinical significance of placental histological lesions in an unselected population at or near term. Virchows Arch. 2011;459(6):565–572.
- Leistra-Leistra MJ, Timmer A, van Spronsen FJ, et al. Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis? Placenta. 2004; 25:S102–S105.
- Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7(5):443–452.
- Saleemuddin A, Tantbirojn P, Sirois K, et al. Obstetric and perinatal complications in placentas with fetal thrombotic vasculopathy. Pediatr Dev Pathol. 2010;13(6):459–464.
- Chisholm KM, Heerema-McKenney AH. Fetal thrombotic vasculopathy: significance in liveborn children using proposed society for pediatric pathology diagnostic criteria. Am J Surg Pathol. 2015;39(2):274–280.
- Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol. 1995;26(1):80–85.
- Leveno KJ, Quirk JG Jr, Cunningham FG, et al. Prolonged pregnancy. I. Observations concerning the causes of fetal distress. Am J Obstet Gynecol. 1984;150(5 Pt 1):465–473.
- Fox H. Pathology of the placenta. London (UK): Saunders; 1997.
- Stanek J. Segmental villous mineralization: a placental feature of fetal vascular malperfusion. Placenta. 2019;86:20–27.
- Vik T, Redline R, Nelson KB, et al. The placenta in neonatal encephalopathy: a case-control study. J Pediatr. 2018;202:77–85.